Provided by Tiger Trade Technology Pte. Ltd.

Xtant Medical

0.3249
-0.0084-2.52%
Post-market: 0.32490.00000.00%19:30 EDT
Volume:143.97K
Turnover:46.72K
Market Cap:45.49M
PE:-4.08
High:0.3400
Open:0.3400
Low:0.3200
Close:0.3333
52wk High:0.9500
52wk Low:0.2702
Shares:140.00M
Float Shares:54.29M
Volume Ratio:0.28
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0795
EPS(LYR):0.0300
ROE:-25.16%
ROA:-3.75%
PB:1.14
PE(LYR):10.83

Loading ...

Xtant Medical resumed with a Buy at Maxim

TIPRANKS
·
Apr 20

Adagio Medical ULTA technology featured in scientific sessions at Heart Rhythm 2026 conference

Reuters
·
Apr 16

Xtant Medical Expands Portfolio with HEMOBLAST Distribution Deal

TIPRANKS
·
Apr 13

Xtant Medical wins exclusive US distribution rights for Dilon hemostat HEMOBLAST Bellows

Reuters
·
Apr 13

Xtant Medical Holdings Inc - Integrates Dilon's About 20-Person U.S. Sales Team Into Co

THOMSON REUTERS
·
Apr 13

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's Hemoblast® Bellows Product

THOMSON REUTERS
·
Apr 13

Adagio Medical wins FDA IDE approval for next-gen vCLAS ventricular ablation system trial expansion

Reuters
·
Apr 08

Adagio Medical to present at Needham Virtual Conference

Reuters
·
Apr 06

Adagio Medical says pivotal FULCRUM-VT ULTA trial results set for HRS late-breaking session

Reuters
·
Apr 01

Xtant Medical Earnings Call Highlights Profitability Turnaround

TIPRANKS
·
Apr 01

Xtant Medical FY25 net income rises to $5 million; revenue increases 14% to $134 million

Reuters
·
Apr 01

Xtant Medical Holdings Is Maintained at Buy by BTIG

Dow Jones
·
Mar 31

Xtant Medical Q4 sales rise on higher licensing revenue

Reuters
·
Mar 31

Xtant Medical Hldgs Q4 Sales $32.357M Beat $30.750M Estimate

Benzinga Earnings
·
Mar 31

BRIEF-Xtant Medical Q4 Revenue USD 32.4 Million

Reuters
·
Mar 31

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

THOMSON REUTERS
·
Mar 31

Xtant Medical Q4 Net Income USD 100 Thousand

THOMSON REUTERS
·
Mar 31

Xtant Medical Q4 EPS USD 0

THOMSON REUTERS
·
Mar 31

Adagio Medical FY2025 net loss narrows 66.55% to $25 million; revenue falls to no revenue

Reuters
·
Mar 27

Xtant Medical updates financial calendar; Q4 and FY2025 results set for premarket release and conference call at 8:30 AM ET

Reuters
·
Mar 25